A key finding in the origins of lupus has been discovered. In those with systemic lupus erythematosus, B cells are abnormally activated. This results in the production of antibodies which react against the patient's own tissue, causing a range of symptoms including rashes, joint pain, and fatigue.
Researchers discover brain like activity in the immune system. The Nature study reveals T cells in the immune system transfer dopamine to B cells, providing motivation for these cells to produce antibodies and battle infection. The researchers hope their findings will help develop treatments to make immune response to vaccines and infections faster, and slow autoimmune conditions.
Researchers have identified 27 genes in brain stem cells that are prone to double strand breaks, a form of DNA damage.
A new study reveals the intestine as a source of immune cells that help reduce neuroinflammation in patients with multiple sclerosis. Increasing the number of these cells helps block inflammation entirely, researchers report.
A new study reports immune cells that help us fight off infections may play a larger role in Alzheimer's disease than researchers previously thought.
According to a new study, an experimental drug called laquinimod may help to prevent the development of and reduce the progression of multiple sclerosis.
FDA approves a new drug to treat both relapsing-remitting multiple sclerosis and primary progressive MS.
Capsular polysaccharide A (PSA), an envelope molecule, may help to boost the immune system and protect against potentially fatal neuroinflammation associated with Herpes Simplex Encephalitis (HSE). Mice given PSA survived exposure to a lethal herpes simplex viral infection, while those not treated with the probiotic did not, despite both groups being treated with a common antiviral used to treat HSE.